<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">7729</item><item key="factors"><item><item key="GSM1533823"><item key="treatment">4T1 mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Metastatic</item></item></item><item><item key="GSM1533823"><item key="treatment">4T1 mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Metastatic</item></item></item><item><item key="GSM1533823"><item key="treatment">4T1 mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Metastatic</item></item></item><item><item key="GSM1533823"><item key="treatment">4T1 mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Metastatic</item></item></item><item><item key="GSM1533828"><item key="treatment">67NR mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Non-metastatic</item></item></item><item><item key="GSM1533828"><item key="treatment">67NR mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Non-metastatic</item></item></item><item><item key="GSM1533828"><item key="treatment">67NR mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Non-metastatic</item></item></item><item><item key="GSM1533828"><item key="treatment">67NR mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Non-metastatic</item></item></item><item><item key="GSM1533828"><item key="treatment">67NR mouse breast carcinoma cell line injected into fourth mammary fat pad of BALB/c mouse</item><item key="organism part">Lung, Non-metastatic</item></item></item><item><item key="GSM1533833"><item key="treatment">PBS control</item><item key="organism part">Lung, Normal</item></item></item><item><item key="GSM1533833"><item key="treatment">PBS control</item><item key="organism part">Lung, Normal</item></item></item><item><item key="GSM1533833"><item key="treatment">PBS control</item><item key="organism part">Lung, Normal</item></item></item><item><item key="GSM1533833"><item key="treatment">PBS control</item><item key="organism part">Lung, Normal</item></item></item><item><item key="GSM1533833"><item key="treatment">PBS control</item><item key="organism part">Lung, Normal</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">Determine gene expression differences between normal, metastatic and non-metastatic mouse lung tissue. Priming of the organ-specific...</item><item key="pubmed_id">21081700</item><item key="geo_gse_id">E-GEOD-62817</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">14</item><item key="tags"><item>breast</item><item>breast carcinoma</item><item>carcinoma</item><item>cell</item><item>liver</item><item>lung</item><item>lung metastasis</item><item>organ</item><item>protein</item><item>volume</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">spr509-lung-metastasis</item><item key="geo_id_plat">E-GEOD-62817_A-AFFY-45</item><item key="name">SPR509: Lung metastasis</item><item key="created">Nov.12, 2014</item><item key="summary">Determine gene expression differences between normal, metastatic and non-metastatic mouse lung tissue. Priming of the organ-specific premetastatic sites is thought to be an important yet incompletely understood step during metastasis. In this study, we show that the metastatic tumors we examined overexpress granulocyte-colony stimulating factor (G-CSF), which expands and mobilizes Ly6G+Ly6C+ granulocytes and facilitates their subsequent homing at distant organs even before the arrival of tumor cells. Moreover, G-CSF-mobilized Ly6G+Ly6C+ cells produce the Bv8 protein, which has been implicated in angiogenesis and mobilization of myeloid cells. Anti-G-CSF or anti-Bv8 antibodies significantly reduced lung metastasis. Transplantation of Bv8 null fetal liver cells into lethally irradiated hosts also reduced metastasis. We identified an unexpected role for Bv8: the ability to stimulate tumor cell migration through activation of one of the Bv8 receptors, prokineticin receptor (PKR)-1. Finally, we show that administration of recombinant G-CSF is sufficient to increase the numbers of Ly6G+Ly6C+ cells in organ-specific metastatic sites and results in enhanced metastatic ability of several tumors. 67NR and 4T1mouse breast carcinoma cell lines were injected into fourth mammary fat pad; lung tissue was collected when tumor reached volume of 50mm3. RNA was extracted using Qiagen kit.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-62817</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-62817/samples/</item></data></biogps>
